Prof. Dr. ir. Kathleen Claes (°1973) obtained her Ph.D. degree in 2003. She is associate professor at Ghent University and PI of CRIG (Cancer Research Institute Ghent). Her major research interest involves cancer predisposition and precision oncology. She is heading the ISO15189-accredited Laboratory of Molecular Genetics at the Center for Medical Genetics (CMGG), Ghent University Hospital. She has a major expertise in molecular tests for (hereditary) cancer. At the international level, she is active in several working groups of ENIGMA (https://enigmaconsortium.org/) and CIMBA (http://cimba.ccge.medschl.cam.ac.uk/). She is work package leader in the ERN GENTURIS (https://www.genturis.eu/). She chairs the BELMOLGEN working group of the Belgian Society of Human Genetics (http://www.beshg.be/) and is treasurer of FAPA (https://belgianfapa.be/). She has (co-)authored more than 120 A1 publications. She is a member of the editorial board of Nature Scientific Reports. She serves on the advisory boards of (inter)national funding bodies and research councils.